Yoichi Hayakawa
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis 74
- Biotechnology top 0.5%
- Marine Sponges and Natural Products 17
- Microbial Metabolism and Applications 12
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 18
- Organic Chemistry top 1%
- Synthetic Organic Chemistry Methods 13
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 24
- Natural product bioactivities and synthesis 10
-
- Synthesis and Biological Activity 10
- Co-authors
- Haruo SetoKazuo Shin‐yaKazuo FurihataNOBORU OTAKETakashi KawasakiMasaya NakagawaToshio OhtaniKonstanty Wierzba
- Cited by
- PharmacologyBiotechnologyToxicology
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Yoichi Hayakawa
154 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 1.6k
- Biotechnology 768
- Toxicology 198
- Organic Chemistry 1.6k
- Molecular Biology 2.2k
Countries citing papers authored by Yoichi Hayakawa
This map shows the geographic impact of Yoichi Hayakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Hayakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Hayakawa more than expected).
Fields of papers citing papers by Yoichi Hayakawa
This network shows the impact of papers produced by Yoichi Hayakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Hayakawa. The network helps show where Yoichi Hayakawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoichi Hayakawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 1 | |
| 3 | 2020 | 4 | |
| 4 | 2020 | 1 | |
| 5 | 2018 | 11 | |
| 6 | 2014 | 13 | |
| 7 | 2013 | 25 | |
| 8 | 2007 | 19 | |
| 9 | Streptomyces olivoviridisの形質転換細胞における新しいアポトーシス誘導剤,チオビリダミド | 2006 | 1 |
| 10 | 2006 | 58 | |
| 11 | 2004 | 24 | |
| 12 | 2004 | 178 | |
| 13 | 2003 | 10 | |
| 14 | 2001 | 13 | |
| 15 | 2000 | 20 | |
| 16 | 1997 | 37 | |
| 17 | 1997 | 33 | |
| 18 | 1996 | 8 | |
| 19 | 1995 | 35 | |
| 20 | 1989 | 26 |
About Yoichi Hayakawa
Yoichi Hayakawa is a scholar working on Toxicology, Pharmacology and Biotechnology, having authored 158 papers that have together received 4.0k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (74 papers), Cancer therapeutics and mechanisms (24 papers), Bioactive Compounds and Antitumor Agents (18 papers), Marine Sponges and Natural Products (17 papers), Synthetic Organic Chemistry Methods (13 papers), Microbial Metabolism and Applications (12 papers), Natural product bioactivities and synthesis (10 papers) and Synthesis and Biological Activity (10 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biotechnology (768 citations) and Toxicology (198 citations). Yoichi Hayakawa has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Haruo Seto, Kazuo Shin‐ya, Kazuo Furihata, NOBORU OTAKE, Takashi Kawasaki, Masaya Nakagawa, Toshio Ohtani, Konstanty Wierzba, Yuji Yamada and Koji Nagai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.